Matches in Nanopublications for { ?s ?p "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP649143.RAlKBmBC6rdO3uQ6TrFvo3yVCjuB7ZO5WTq52xx9Fu4JM130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649143.RAlKBmBC6rdO3uQ6TrFvo3yVCjuB7ZO5WTq52xx9Fu4JM130_provenance.
- assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_provenance.
- assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1311943.RAYhJR-M4tBJuKeLl4aVliC4zJtXxcAMPFyuQBCjkuCIs130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311943.RAYhJR-M4tBJuKeLl4aVliC4zJtXxcAMPFyuQBCjkuCIs130_provenance.
- NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_provenance.
- NP1311942.RAqzfgP6DC8Lc_9QoKqUCVVMdhdPCVOst8dz92rB47SHw130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311942.RAqzfgP6DC8Lc_9QoKqUCVVMdhdPCVOst8dz92rB47SHw130_provenance.
- NP1311944.RAmY2osyr0ado8hRaS-gL8v1AN04tZUE4eJt_wl7Q7Xuk130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311944.RAmY2osyr0ado8hRaS-gL8v1AN04tZUE4eJt_wl7Q7Xuk130_provenance.
- NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_provenance.
- NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_provenance.